Cargando…

Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity

In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sæbø, Ingvill Pedersen, Bjørås, Magnar, Franzyk, Henrik, Helgesen, Emily, Booth, James Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917735/
https://www.ncbi.nlm.nih.gov/pubmed/36769243
http://dx.doi.org/10.3390/ijms24032914
_version_ 1784886439207501824
author Sæbø, Ingvill Pedersen
Bjørås, Magnar
Franzyk, Henrik
Helgesen, Emily
Booth, James Alexander
author_facet Sæbø, Ingvill Pedersen
Bjørås, Magnar
Franzyk, Henrik
Helgesen, Emily
Booth, James Alexander
author_sort Sæbø, Ingvill Pedersen
collection PubMed
description In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substantially. This leads to significant difficulties both in interpreting and in comparing the obtained values. Here, we examine how the different variables used under different experimental setups may affect the outcome of this assay. We find that certain key parameters affect the hemolysis measurements in a critical manner. The hemolytic effect of compounds tested here varied up to fourfold depending on the species of the blood source. The use of different types of detergents used for generating positive control samples (i.e., 100% hemolysis) produced up to 2.7-fold differences in the calculated hemolysis ratios. Furthermore, we find an expected, but substantial, increase in the number of hemolyzed erythrocytes with increasing erythrocyte concentration and with prolonged incubation time, which in turn affects the calculated hemolysis ratios. Based on our findings we propose an optimized protocol in an attempt to standardize future hemolysis studies.
format Online
Article
Text
id pubmed-9917735
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99177352023-02-11 Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity Sæbø, Ingvill Pedersen Bjørås, Magnar Franzyk, Henrik Helgesen, Emily Booth, James Alexander Int J Mol Sci Article In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substantially. This leads to significant difficulties both in interpreting and in comparing the obtained values. Here, we examine how the different variables used under different experimental setups may affect the outcome of this assay. We find that certain key parameters affect the hemolysis measurements in a critical manner. The hemolytic effect of compounds tested here varied up to fourfold depending on the species of the blood source. The use of different types of detergents used for generating positive control samples (i.e., 100% hemolysis) produced up to 2.7-fold differences in the calculated hemolysis ratios. Furthermore, we find an expected, but substantial, increase in the number of hemolyzed erythrocytes with increasing erythrocyte concentration and with prolonged incubation time, which in turn affects the calculated hemolysis ratios. Based on our findings we propose an optimized protocol in an attempt to standardize future hemolysis studies. MDPI 2023-02-02 /pmc/articles/PMC9917735/ /pubmed/36769243 http://dx.doi.org/10.3390/ijms24032914 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sæbø, Ingvill Pedersen
Bjørås, Magnar
Franzyk, Henrik
Helgesen, Emily
Booth, James Alexander
Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
title Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
title_full Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
title_fullStr Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
title_full_unstemmed Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
title_short Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
title_sort optimization of the hemolysis assay for the assessment of cytotoxicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917735/
https://www.ncbi.nlm.nih.gov/pubmed/36769243
http://dx.doi.org/10.3390/ijms24032914
work_keys_str_mv AT sæbøingvillpedersen optimizationofthehemolysisassayfortheassessmentofcytotoxicity
AT bjørasmagnar optimizationofthehemolysisassayfortheassessmentofcytotoxicity
AT franzykhenrik optimizationofthehemolysisassayfortheassessmentofcytotoxicity
AT helgesenemily optimizationofthehemolysisassayfortheassessmentofcytotoxicity
AT boothjamesalexander optimizationofthehemolysisassayfortheassessmentofcytotoxicity